369 results on '"MacGrogan, Gaëtan"'
Search Results
2. Neoadjuvant chemotherapy and radiotherapy for locally advanced breast cancer: Safety and efficacy of reverse sequence compared to standard technique?
3. PTEN alterations in sporadic and BRCA1-associated triple negative breast carcinomas
4. Impact of the COVID-19 lockdown in France on the diagnosis and staging of breast cancers in a tertiary cancer centre
5. Interobserver variability in the assessment of stromal tumor-infiltrating lymphocytes (sTILs) in triple-negative invasive breast carcinoma influences the association with pathological complete response: the IVITA study
6. Mise à jour 2021 des recommandations du GEFPICS pour l’évaluation du statut HER2 dans les cancers infiltrants du sein en France
7. Triple-negative breast lobular carcinoma: a luminal androgen receptor carcinoma with specific ESRRA mutations
8. Solid-type adenoid cystic carcinoma of the breast, a distinct molecular entity enriched in NOTCH and CREBBP mutations
9. Interobserver variability in upfront dichotomous histopathological assessment of ductal carcinoma in situ of the breast: the DCISion study
10. Phenotypic discordance between primary and metastatic breast cancer in the large-scale real-life multicenter French ESME cohort
11. Terahertz refractive index-based morphological dilation for breast carcinoma delineation
12. Recommandations du GEFPICS pour la prise en charge des prélèvements dans le cadre du traitement néoadjuvant du cancer du sein
13. Residual cancer burden index and tumor-infiltrating lymphocyte subtypes in triple-negative breast cancer after neoadjuvant chemotherapy
14. A single-center study on total mastectomy versus skin-sparing mastectomy in case of pure ductal carcinoma in situ of the breast
15. Medullary Breast Carcinoma, a Triple-Negative Breast Cancer Associated with BCLG Overexpression
16. Solid papillary carcinoma with reverse polarity of the breast harbors specific morphologic, immunohistochemical and molecular profile in comparison with other benign or malignant papillary lesions of the breast: a comparative study of 9 additional cases
17. Lésions frontières en pathologie mammaire à fort risque de surdiagnostic : lesquelles ? Double lecture anatomopathologique, une nécessité ?
18. Genome profiling is an efficient tool to avoid the STUMP classification of uterine smooth muscle lesions: a comprehensive array-genomic hybridization analysis of 77 tumors
19. Alternative PDGFD rearrangements in dermatofibrosarcomas protuberans without PDGFB fusions
20. Efficacy of antiandrogens in androgen receptor-positive triple-negative metastatic breast cancer: Real-life data
21. Supplementary Data Table from The Nanocind Signature Is an Independent Prognosticator of Recurrence and Death in Uterine Leiomyosarcomas
22. Data from CD95L Cell Surface Cleavage Triggers a Prometastatic Signaling Pathway in Triple-Negative Breast Cancer
23. Supplementary Figures 1 - 5 from CD95L Cell Surface Cleavage Triggers a Prometastatic Signaling Pathway in Triple-Negative Breast Cancer
24. Supplementary Methods from CD95L Cell Surface Cleavage Triggers a Prometastatic Signaling Pathway in Triple-Negative Breast Cancer
25. SOX10, GATA3, GCDFP15, Androgen Receptor, and Mammaglobin for the Differential Diagnosis Between Triple-negative Breast Cancer and TTF1-negative Lung Adenocarcinoma
26. Standardization of pathologic evaluation and reporting of postneoadjuvant specimens in clinical trials of breast cancer: recommendations from an international working group
27. Uterine smooth muscle tumor analysis by comparative genomic hybridization: a useful diagnostic tool in challenging lesions
28. Lésions « à risque » et frontières
29. Mise à jour 2014 des recommandations du GEFPICS pour l’évaluation du statut HER2 dans les cancers du sein en France
30. Recommandations du GEFPICS concernant la phase pré-analytique pour l’évaluation de HER2 et des récepteurs hormonaux dans le cancer du sein : mise à jour 2014
31. Le cancer du sein triple-négatif. Le triple-négatif est fréquent chez les patientes mutées : comment ne pas le rater ? Comment le caractériser ? De manière plus générale, l’imagerie peut-elle orienter vers le diagnostic histologique ?
32. YWHAE rearrangement identified by FISH and RT-PCR in endometrial stromal sarcomas: genetic and pathological correlations
33. Comprehensive prognostic analysis in breast cancer integrating clinical, tumoral, micro-environmental and immunohistochemical criteria
34. The Role of Sentinel Lymph Node Biopsy and Factors Associated with Invasion in Extensive DCIS of the Breast Treated by Mastectomy: The Cinnamome Prospective Multicenter Study
35. Predictive value and clinical utility of centrally assessed ER, PgR, and Ki-67 to select adjuvant endocrine therapy for premenopausal women with hormone receptor-positive, HER2-negative early breast cancer: TEXT and SOFT trials
36. Accuracy of HER2 status determination on breast core-needle biopsies (immunohistochemistry, FISH, CISH and SISH vs FISH)
37. Scanning point terahertz source microscopy of unstained comedo ductal carcinoma in situ
38. Abstract P2-07-10: Germline BRCA screening for locally advanced breast cancer treated by neoadjuvant chemotherapy: Defining a subgroup with high rate of mutation and local relapses
39. Liste des auteurs
40. All atypia diagnosed at stereotactic vacuum-assisted breast biopsy do not need surgical excision
41. Scanning point terahertz source microscopy of unstained comedo ductal carcinoma in situ
42. Impact of the COVID-19 lockdown in France on the diagnosis and staging of breast cancers in a tertiary cancer centre
43. Breast hamartoma: reassessment of an under‐recognised breast lesion
44. Prediction of HER2 gene status in Her2 2+ invasive breast cancer: a study of 108 cases comparing ASCO/CAP and FDA recommendations
45. D2-40 in breast cancer: should we detect more vascular emboli?
46. Automate à inclusion rapide : l’expérience bordelaise
47. Label-Free Observation of Micrometric Inhomogeneity of Human Breast Cancer Cell Density Using Terahertz Near-Field Microscopy
48. Gene expression profile predicts outcome after anthracycline-based adjuvant chemotherapy in early breast cancer
49. Instant-quality fluorescence in-situ hybridization as a new tool for HER2 testing in breast cancer: a comparative study
50. Terahertz near-field imaging of highly-malignant early-stage breast cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.